Redosing study… [Study As­sess­ment]

posted by luvblooms  – India, 2011-06-18 13:47 (5491 d 22:06 ago) – Posting: # 7153
Views: 12,925

Hello EM,

❝ Yes, this spells trouble. Highly variable drug 'in some patients'. Or highly variable patients among your study population.


Yes!!!! But again issue is how to identify the highly variable volunteer.

❝ I can't imagine a solution in the concrete situation, especially not when non-parametrics are discouraged.


Now planning to put a day housing before the study to minimize the physiological based variation. Let's see.

Luv

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
194 visitors (0 registered, 194 guests [including 14 identified bots]).
Forum time: 11:53 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5